evidencegaps
Primary study · included by 1 review

Refining the clinical utility of [177Lu]Lu/[225Ac]Ac-PSMA tandem RLT in patients with metastatic castration resistant prostate cancer.

Widjaja 2025 · Widjaja Liam, Hornfeck Johannes, Siegmund Sophie C, et al. · European journal of nuclear medicine and molecular imaging · 2026

Included by

Beyond [177Lu]Lu-PSMA: a meta-analysis of safety and efficacy of emerging PSMA radioligand therapy agents.
Non-Cochrane · intervention · 2026 · cited as Widjaja 2025 · Reference list refs 21-53; Table 2; Supplementary Table 5

The review does not say which of its outcomes this study informs.

1 including review in total.